Doxazosin Mesylate

CAS 77883-43-3 11 FDA-DMF suppliersSmall Molecule

Overview

Doxazosin Mesylate is an alpha-1 adrenergic blocker used primarily to treat hypertension and benign prostatic hyperplasia. It relaxes blood vessels and muscles in the prostate and bladder neck, making it easier to urinate and lower blood pressure.

API suppliers (10)

Suppliers of Doxazosin Mesylate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • EXCELLA GMBH AND CO KG1 active DMF
  • EXCELLA GMBH AND CO KG1 active DMF
  • EXCELLA GMBH AND CO KG1 active DMF
  • STANDARD CHEM AND PHARM CO LTD
  • Cipla USA, Inc.USA
  • BASF PHARMACHEMIKALIEN GMBH CO KG
  • CILAG AGSwitzerland
  • PHARMACEUTICAL FINE CHEMICALS PFC BAHAMAS LTD
  • MEDICHEM SASpain
  • Wockhardt LimitedIndia

Therapeutic areas

CardiovascularUrology

Related APIs

Prazosin Hydrochloride
12 suppliers
Phentolamine Mesylate
5 suppliers
Rivaroxaban
57 suppliers
Apixaban
51 suppliers
Telmisartan
43 suppliers
Empagliflozin
42 suppliers
Clopidogrel
40 suppliers
Olmesartan Medoxomil
38 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo